tiprankstipranks
MAIA Biotechnology, Inc. (MAIA)
NYSE MKT:MAIA
US Market

MAIA Biotechnology, Inc. (MAIA) Financial Statements

106 Followers

MAIA Biotechnology, Inc. Financial Overview

MAIA Biotechnology, Inc.'s market cap is currently ―. The company's EPS TTM is $-1.534; its P/E ratio is -2.37; MAIA Biotechnology, Inc. is scheduled to report earnings on August 19, 2024, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -8.09M$ -6.26M$ -4.88M$ -4.52M$ -4.11M
EBITDA$ -8.09M$ -6.26M$ -4.88M$ -4.52M$ -4.11M
Net Income Common Stockholders$ -8.07M$ -6.26M$ -4.88M$ -4.52M$ -4.12M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.27M$ 7.15M$ 6.10M$ 9.15M$ 7.59M
Total Assets$ 8.72M$ 7.57M$ 7.00M$ 10.27M$ 9.07M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -8.27M$ -7.15M$ -6.10M$ -9.15M$ -7.59M
Total Liabilities$ 14.48M$ 7.09M$ 4.25M$ 3.39M$ 3.99M
Stockholders Equity$ -5.76M$ 477.51K$ 2.75M$ 6.87M$ 5.08M
Cash Flow-
Free Cash Flow$ -3.59M$ -3.99M$ -3.16M$ -2.56M$ -3.36M
Operating Cash Flow$ -3.59M$ -3.99M$ -3.16M$ -2.56M$ -3.36M
Investing Cash Flow-----
Financing Cash Flow$ 4.72M$ 5.03M$ 125.94K$ 4.12M-
Currency in USD

MAIA Biotechnology, Inc. Earnings and Revenue History

MAIA Biotechnology, Inc. Debt to Assets

MAIA Biotechnology, Inc. Cash Flow

MAIA Biotechnology, Inc. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis